News Juno halts CAR-T trial again after 2 more deaths Doubts over Juno CAR-T therapy after two more trial deaths.
News Alnylam plunges after deaths in rare disease trial Biotech axes revusiran due to safety concerns.
News Sandoz, Teva and Mylan generics to be suspended in EU Regulator concerned over data from contract research organisation.
News Patients may have quit statins after media row Coverage may have given "disproportional weight" to concerns over side effects.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
